Abstract
Multiagent Induction Chemotherapy With Duration Longer Than 4 Months Improves Survival in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Who Received Stereotactic Body Radiation Therapy
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
